![Driver Group Plc](/common/images/company/L_DRV.png)
WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company advancing novel multi-targeted...
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 2 | 8.33333333333 | 24 | 26 | 22 | 26747 | 24.15660405 | DE |
26 | -2.5 | -8.77192982456 | 28.5 | 28.5 | 22 | 24008 | 25.12450578 | DE |
52 | -4 | -13.3333333333 | 30 | 30 | 22 | 22185 | 25.98016556 | DE |
156 | -27.5 | -51.4018691589 | 53.5 | 70 | 22 | 43192 | 38.10378481 | DE |
260 | -31.5 | -54.7826086957 | 57.5 | 73.5 | 22 | 82030 | 50.78869933 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.